Showing results (171-180 of 219) with videos related to
Sort By:
Pageof 22
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2017
Efficacy and safety of nilotinib in patients with KIT-mutated metastatic or inoperable melanoma: final results from the global, single-arm, phase II TEAM trialJ Guo, R D Carvajal, R Dummer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2019
First-In-Human Study of Cemiplimab Alone or In Combination with Radiotherapy and/or Low-dose Cyclophosphamide in Patients with Advanced MalignanciesKyriakos P Papadopoulos, Melissa L Johnson, Albert C Lockhart, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2018
Hybrid Capture-Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Cancers of the Gastrointestinal Tract or AnusAlexa B Schrock, Dean Pavlick, Samuel J Klempner, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2020
OX40 Agonist BMS-986178 Alone or in Combination With Nivolumab and/or Ipilimumab in Patients With Advanced Solid TumorsMartin Gutierrez, Victor Moreno, Kimberley M Heinhuis, et al.Journal of Oncology|January 29, 2021
MicroRNA-Based Cancer Mortality Risk Scoring System and hTERT Expression in Early-Stage Oral Squamous Cell CarcinomaAngela J Yoon, Regina M Santella, Shuang Wang, et al.Cancer Research|January 18, 2020
Linking Transcriptomic and Imaging Data Defines Features of a Favorable Tumor Immune Microenvironment and Identifies a Combination Biomarker for Primary MelanomaRobyn D Gartrell-Corrado, Andrew X Chen, Emanuelle M Rizk, et al.Pigment Cell & Melanoma Research|August 13, 2014
Biology of advanced uveal melanoma and next steps for clinical therapeuticsJason J Luke, Pierre L Triozzi, Kyle C McKenna, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 5, 2022
Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring CCNE1 AmplificationSiqing Fu, Shuyang Yao, Yuan Yuan, et al.Nature Medicine|October 13, 2022
Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trialRichard D Carvajal, Marcus O Butler, Alexander N Shoushtari, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2016
Combined KIT and CTLA-4 Blockade in Patients with Refractory GIST and Other Advanced Sarcomas: A Phase Ib Study of Dasatinib plus IpilimumabSandra P D'Angelo, Alexander N Shoushtari, Mary Louise Keohan, et al.Pageof 22